Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60
William C. Reinhold, Margot Sunshine, Sudhir Varma, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 17, pp. 3841-3852
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
David S. Liu, Cuong Duong, Sue Haupt, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 291
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
Junko Murai, Ying Feng, Guoying Karen Yu, et al.
Oncotarget (2016) Vol. 7, Iss. 47, pp. 76534-76550
Open Access | Times Cited: 254
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Augustin Luna, Fathi Elloumi, Sudhir Varma, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1083-D1093
Open Access | Times Cited: 156
CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines
Vinodh N. Rajapakse, Augustin Luna, Mihoko Yamade, et al.
iScience (2018) Vol. 10, pp. 247-264
Open Access | Times Cited: 145
Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
Junko Murai, Anish Thomas, Markku Miettinen, et al.
Pharmacology & Therapeutics (2019) Vol. 201, pp. 94-102
Open Access | Times Cited: 135
ONC201 kills breast cancer cellsin vitroby targeting mitochondria
Yoshimi Endo Greer, Natalie Porat‐Shliom, Kunio Nagashima, et al.
Oncotarget (2018) Vol. 9, Iss. 26, pp. 18454-18479
Open Access | Times Cited: 88
Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment
Qiang Song, Hao Yu, Yidong Cheng, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42
CLC-Pred 2.0: A Freely Available Web Application for In Silico Prediction of Human Cell Line Cytotoxicity and Molecular Mechanisms of Action for Druglike Compounds
Alexey A. Lagunin, Anastasia V. Rudik, Pavel V. Pogodin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1689-1689
Open Access | Times Cited: 41
NCI-60 Cell Line Screening: A Radical Departure in its Time
Bruce A. Chabner
JNCI Journal of the National Cancer Institute (2016) Vol. 108, Iss. 5, pp. djv388-djv388
Open Access | Times Cited: 79
Targeting DNA repair and replication stress in the treatment of ovarian cancer
Junko Murai
International Journal of Clinical Oncology (2017) Vol. 22, Iss. 4, pp. 619-628
Closed Access | Times Cited: 74
Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer
Elie Hatem, Sandy Azzi, Nadine El Banna, et al.
JNCI Journal of the National Cancer Institute (2018) Vol. 111, Iss. 6, pp. 597-608
Open Access | Times Cited: 72
Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress
Junko Murai, Hongliang Zhang, Lőrinc Sándor Pongor, et al.
Cell Reports (2020) Vol. 30, Iss. 12, pp. 4137-4151.e6
Open Access | Times Cited: 68
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer
Natalya Beglyarova, Eugenia Banina, Yan Zhou, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 24, pp. 6153-6163
Open Access | Times Cited: 61
Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase Expression
Daniel Rathkey, Manakamana Khanal, Junko Murai, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 5, pp. 843-859
Open Access | Times Cited: 58
A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression
Yue Zhao, Li Xu, Xinyu Wang, et al.
Molecular Oncology (2021) Vol. 15, Iss. 4, pp. 1088-1109
Open Access | Times Cited: 49
The NCI-60 Methylome and Its Integration into CellMiner
William C. Reinhold, Sudhir Varma, Margot Sunshine, et al.
Cancer Research (2016) Vol. 77, Iss. 3, pp. 601-612
Open Access | Times Cited: 54
Next generation diversity-oriented synthesis: a paradigm shift from chemical diversity to biological diversity
Ivan Pavlinov, Erica M. Gerlach, Leslie N. Aldrich
Organic & Biomolecular Chemistry (2018) Vol. 17, Iss. 7, pp. 1608-1623
Closed Access | Times Cited: 54
Identification of tRNA-derived ncRNAs in TCGA and NCI-60 panel cell lines and development of the public database tRFexplorer
Alessandro La Ferlita, Salvatore Alaimo, Dario Veneziano, et al.
Database (2019) Vol. 2019
Open Access | Times Cited: 47
Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients
Yuanyuan Li, Bingbin Dong, Wei Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations
William C. Reinhold, Kelli M. Wilson, Fathi Elloumi, et al.
Cancer Research (2023) Vol. 83, Iss. 12, pp. 1941-1952
Open Access | Times Cited: 16
Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity
Zhenghao Chen, Youquan Zhao, Ye Tian, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 282-282
Open Access | Times Cited: 14
A novel mitochondria-related gene signature in esophageal carcinoma: prognostic, immune, and therapeutic features
Xintong Zhang, Hao Wu, Jingjing Niu, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 13
HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process
Sijia Ma, Jia Wang, Zhiwei Cui, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents
Xiaoru Zhang, Haowen Wang, Wen-Lin Tang, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 9908-9930
Open Access | Times Cited: 42
Schlafens Can Put Viruses to Sleep
Eui Tae Kim, Matthew D. Weitzman
Viruses (2022) Vol. 14, Iss. 2, pp. 442-442
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top